Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Colorcon
Baxter
Boehringer Ingelheim
Johnson and Johnson
Medtronic

Last Updated: December 7, 2021

DrugPatentWatch Database Preview

Litigation Details for Helsinn Healthcare SA v. Cipla Ltd. (D. Del. 2013)


Email this page to a colleague

« Back to Dashboard

Small Molecule Drugs cited in Helsinn Healthcare SA v. Cipla Ltd.
The small molecule drug covered by the patents cited in this case is ⤷  Try it Free .

Details for Helsinn Healthcare SA v. Cipla Ltd. (D. Del. 2013)

Date Filed Document No. Description Snippet Link To Document
2013-04-16 1 States Patent No. 7,947,724 (“the ’724 patent”), United States Patent No. 7,947,725 (“the ’725 patent”), …United States Patent No. 7,960,424 (“the ’424 patent”). This action arises under the patent laws of the …Delaware residents. THE PATENTS-IN-SUIT 11. On May 24, 2011, the ’724 patent, titled “Liquid Pharmaceutical…copy of the ’724 patent is attached as Exhibit A. 12. On May 24, 2011, the ’725 patent, titled “Liquid…’724 patent are invalid. Aurobindo did not allege noninfringement of any claim of the ’724 patent, separate External link to document
2014-12-05 119 assert United States Patent Nos. 7,947,724 (“the ’724 patent”), 7,947,725 (“the ’725 patent”), 7,960,424 (“…(“the ’424 patent”), 8,598,219 (“the ’219 patent”), and 8,729,094 (the ’094 patent”) against Mylan, and…and the ’219 and ’094 patents against Cipla. These patents, as well as the intrinsic evidence relied upon…commercial embodiment of the patents-in-suit. One of the central purposes of those patents was to provide sufficiently…disclosed in Example 13 of U.S. Patent No. 5,202,333 (“the ’333 patent”), which contained different amounts External link to document
2015-01-26 139 disputed terms of the patents-in-suit, i.e., U.S. Patent Nos. 7,947,724 (“the ’724 patent”), 7,947,725 (“the… listed patents, i.e., the ’724 patent, the ’725 patent, the ’219 patent, and the ’094 patent. The drug…in U.S. Patent No. 5,202,333, filed in 1991. The ’724 patent, the ’725 patent, the ’219 patent, and the…“the ’725 patent”), 8,598,219 (“the ’219 patent”), and 8,729,094 (“the ’094 patent”). Cipla asks…the ’094 patent, along with several other Orange Book listed patents, including U.S. Patent Nos. 7,960,424 External link to document
2015-02-24 159 limitation of the claims of U.S. Patent No. 8,598,219 (''the '219 patent") and agreed to …is a limitation of the claims of the '219 patent. The parties met and conferred on February…2013 26 October 2015 1:13-cv-00688 830 Patent None District Court, D. Delaware External link to document
2013-10-15 16 infringement of U.S. Patent Nos. 7,947,724, 7,847,725 and 7,960,424 (the "Patents-in-Suit") against… Competition and Patent Term Restoration Act of 1984 as to" each of the Patents-in-Suit. … 27, 2013, United States Patent No. 8,518,981 (''the '981 patent"), titled "Liquid…infringed, or will infringe, any valid claim of the Patents-in- Suit and denied that Aurobindo Pharma USA …quot; issued; WHEREAS the '981 patent is listed in the Orange Book for Aloxi®; External link to document
2015-03-09 169 the asserted claims of U.S. Patent Nos. 7,947,724 ("the '724 Patent"); 7,947,725 ("the… ORDER CONSTRUING THE TERMS OF U.S. PATENT NOS. 7,947,724; 7,947,725; 7,960,424; 8,598,219 & 8,729,094… CONSTRUING THE TERMS OF U.S. PATENT NOS. 7,947,724; 7,947,725; 7,960,424; 8,598,219…;the '725 Patent"); 7,960,424 ("the '424 Patent"); 8,598,219 ("the '…x27;219 Patent"); and 8,729,094 ("the '094 Patent"): The '219 & External link to document
2013-10-15 17 infringement of United States Patent No. 7,947,724 (“the ’724 patent”), United States Patent No. 7,947,725 (“the…’725 patent”), United States Patent No. 7,960,424 (“the ’424 patent”), and United States Patent No. 8,518,9818,518,981 (“the ’981 patent”). This action arises under the patent laws of the United States, 35 U.S.C… THE PATENTS-IN-SUIT 11. On May 24, 2011, the ’724 patent, titled “Liquid… ’724 patent is attached as Exhibit A. 12. On May 24, 2011, the ’725 patent, titled External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Medtronic
Johnson and Johnson
Baxter
Boehringer Ingelheim
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.